The University of Southampton
University of Southampton Institutional Repository

Do lower antenatal blood pressure cut-offs in pregnant women with obesity identify those at greater risk of adverse maternal and perinatal outcomes? A secondary analysis of data from the UK Pregnancies Better Eating and Activity Trial (UPBEAT)

Do lower antenatal blood pressure cut-offs in pregnant women with obesity identify those at greater risk of adverse maternal and perinatal outcomes? A secondary analysis of data from the UK Pregnancies Better Eating and Activity Trial (UPBEAT)
Do lower antenatal blood pressure cut-offs in pregnant women with obesity identify those at greater risk of adverse maternal and perinatal outcomes? A secondary analysis of data from the UK Pregnancies Better Eating and Activity Trial (UPBEAT)
Background: obesity is a major risk-factor for adverse pregnancy outcomes. While the 2017 American College of Cardiology/American Heart Association (ACC/AHA) classification of normal and abnormal blood pressure (BP) outside pregnancy has been suggested for use in pregnancy, the impact on adverse outcomes has not been examined specifically in women with obesity.

Methods: the UK Pregnancies Better Eating and Activity Trial (UPBEAT) enroled women with a body mass index (BMI) ≥ 30 kg/m2. In secondary analyses, maximal antenatal BP was categorised by 2017 ACC/AHA criteria: ‘Normal’ BP (systolic [sBP] <120 mmHg and diastolic [dBP] <80 mmHg), ‘Elevated’ BP (sBP 120–129 mmHg and dBP <80 mmHg), ‘Stage 1 hypertension’ (sBP 130–139 mmHg and/or dBP 80-89 mmHg), and ‘Stage 2 hypertension’ (sBP ≥140 mmHg and/or dBP ≥90 mmHg, non-severe [sBP 140-159 mmHg and/or dBP 90–109 mmHg] and severe (sBP ≥160 mmHg and/or dBP ≥110 mmHg). Main outcomes were preterm birth, postpartum haemorrhage (PPH), birthweight <10th centile (small-for-gestational age, SGA), and neonatal intensive care unit (NICU) admission. Associations with adverse outcomes were adjusted for UPBEAT intervention, maternal age, booking BMI, ethnicity, parity, smoking, alcohol, and previous pre-eclampsia or gestational diabetes. Diagnostic test properties (positive and negative likelihood ratios, -LR and +LR) were assessed as individual categories (vs. ‘Normal’ BP), and as threshold values.

Results: severe ‘Stage 2 hypertension’ (vs. BP < 160/110 mmHg) was associated with PPH (RR 2.57 (1.35, 4.86)) and SGA (RR 2.52 (1.05, 6.07)) only in unadjusted analyses. No outcomes were associated with ‘Stage 1 hypertension’ or ‘Elevated BP’. All +LR were <5.0 and -LR ≥ 0.20, indicating that no BP threshold was useful as a diagnostic test to detect preterm birth, PPH, SGA, or NICU admission.

Conclusions: among pregnant women with obesity, we found no evidence that lowering the antenatal BP considered to be abnormal (from 140/90 mmHg) would assist in identifying women and babies at risk.
0307-0565
Slade, Laura
5287c25a-318a-4d8a-a43e-20a8f0162101
Syeda, N.
db0d4146-6c26-4b92-a191-16ea3ec3c274
Mistry, Hiten D.
f34ad4f6-c76b-4be1-b853-51acd80b0ce7
Bone, Jeffrey N.
da2cde17-ff5d-465e-8a01-472268eac8ed
Wilson, M.
b150dfb8-d36c-4ded-9698-58161955935e
Blackman, M.
e8a815c6-a9e4-49e4-ba7e-e1bdc02f0e5c
Poston, Lucilla
916aced2-462e-445f-9efa-83ed4b7b3a9f
Godfrey, Keith
0931701e-fe2c-44b5-8f0d-ec5c7477a6fd
von Dadelszen, Peter
99289cc7-421a-405b-b2b7-9636ec4818e8
Magee, L.A.
12dc7d1f-b93a-421f-8f47-46e436e5cc30
UPBEAT Consortium
Slade, Laura
5287c25a-318a-4d8a-a43e-20a8f0162101
Syeda, N.
db0d4146-6c26-4b92-a191-16ea3ec3c274
Mistry, Hiten D.
f34ad4f6-c76b-4be1-b853-51acd80b0ce7
Bone, Jeffrey N.
da2cde17-ff5d-465e-8a01-472268eac8ed
Wilson, M.
b150dfb8-d36c-4ded-9698-58161955935e
Blackman, M.
e8a815c6-a9e4-49e4-ba7e-e1bdc02f0e5c
Poston, Lucilla
916aced2-462e-445f-9efa-83ed4b7b3a9f
Godfrey, Keith
0931701e-fe2c-44b5-8f0d-ec5c7477a6fd
von Dadelszen, Peter
99289cc7-421a-405b-b2b7-9636ec4818e8
Magee, L.A.
12dc7d1f-b93a-421f-8f47-46e436e5cc30

Slade, Laura, Syeda, N., Mistry, Hiten D., Bone, Jeffrey N., Wilson, M., Blackman, M., Poston, Lucilla, Godfrey, Keith, von Dadelszen, Peter and Magee, L.A. , UPBEAT Consortium (2025) Do lower antenatal blood pressure cut-offs in pregnant women with obesity identify those at greater risk of adverse maternal and perinatal outcomes? A secondary analysis of data from the UK Pregnancies Better Eating and Activity Trial (UPBEAT). International Journal of Obesity. (doi:10.1038/s41366-025-01803-8).

Record type: Article

Abstract

Background: obesity is a major risk-factor for adverse pregnancy outcomes. While the 2017 American College of Cardiology/American Heart Association (ACC/AHA) classification of normal and abnormal blood pressure (BP) outside pregnancy has been suggested for use in pregnancy, the impact on adverse outcomes has not been examined specifically in women with obesity.

Methods: the UK Pregnancies Better Eating and Activity Trial (UPBEAT) enroled women with a body mass index (BMI) ≥ 30 kg/m2. In secondary analyses, maximal antenatal BP was categorised by 2017 ACC/AHA criteria: ‘Normal’ BP (systolic [sBP] <120 mmHg and diastolic [dBP] <80 mmHg), ‘Elevated’ BP (sBP 120–129 mmHg and dBP <80 mmHg), ‘Stage 1 hypertension’ (sBP 130–139 mmHg and/or dBP 80-89 mmHg), and ‘Stage 2 hypertension’ (sBP ≥140 mmHg and/or dBP ≥90 mmHg, non-severe [sBP 140-159 mmHg and/or dBP 90–109 mmHg] and severe (sBP ≥160 mmHg and/or dBP ≥110 mmHg). Main outcomes were preterm birth, postpartum haemorrhage (PPH), birthweight <10th centile (small-for-gestational age, SGA), and neonatal intensive care unit (NICU) admission. Associations with adverse outcomes were adjusted for UPBEAT intervention, maternal age, booking BMI, ethnicity, parity, smoking, alcohol, and previous pre-eclampsia or gestational diabetes. Diagnostic test properties (positive and negative likelihood ratios, -LR and +LR) were assessed as individual categories (vs. ‘Normal’ BP), and as threshold values.

Results: severe ‘Stage 2 hypertension’ (vs. BP < 160/110 mmHg) was associated with PPH (RR 2.57 (1.35, 4.86)) and SGA (RR 2.52 (1.05, 6.07)) only in unadjusted analyses. No outcomes were associated with ‘Stage 1 hypertension’ or ‘Elevated BP’. All +LR were <5.0 and -LR ≥ 0.20, indicating that no BP threshold was useful as a diagnostic test to detect preterm birth, PPH, SGA, or NICU admission.

Conclusions: among pregnant women with obesity, we found no evidence that lowering the antenatal BP considered to be abnormal (from 140/90 mmHg) would assist in identifying women and babies at risk.

Text
46893_2_merged_1744981294 - Accepted Manuscript
Available under License Creative Commons Attribution.
Download (1MB)
Text
s41366-025-01803-8 - Version of Record
Available under License Creative Commons Attribution.
Download (671kB)

More information

Accepted/In Press date: 30 April 2025
e-pub ahead of print date: 16 June 2025
Published date: August 2025

Identifiers

Local EPrints ID: 502967
URI: http://eprints.soton.ac.uk/id/eprint/502967
ISSN: 0307-0565
PURE UUID: c5f77940-115d-4755-969b-9a5232886f29
ORCID for Keith Godfrey: ORCID iD orcid.org/0000-0002-4643-0618

Catalogue record

Date deposited: 15 Jul 2025 16:45
Last modified: 11 Sep 2025 01:38

Export record

Altmetrics

Contributors

Author: Laura Slade
Author: N. Syeda
Author: Hiten D. Mistry
Author: Jeffrey N. Bone
Author: M. Wilson
Author: M. Blackman
Author: Lucilla Poston
Author: Keith Godfrey ORCID iD
Author: Peter von Dadelszen
Author: L.A. Magee
Corporate Author: UPBEAT Consortium

Download statistics

Downloads from ePrints over the past year. Other digital versions may also be available to download e.g. from the publisher's website.

View more statistics

Atom RSS 1.0 RSS 2.0

Contact ePrints Soton: eprints@soton.ac.uk

ePrints Soton supports OAI 2.0 with a base URL of http://eprints.soton.ac.uk/cgi/oai2

This repository has been built using EPrints software, developed at the University of Southampton, but available to everyone to use.

We use cookies to ensure that we give you the best experience on our website. If you continue without changing your settings, we will assume that you are happy to receive cookies on the University of Southampton website.

×